Skip to Content

Industry, University Deal Moves Novel Cancer Treatment Forward

Abstract artwork of DNA strand in front of math equations

What happens when you put two great biomedical discoveries together? An innovative approach to fighting a major disease.

The University of Minnesota has combined its own patented gene delivery technology with cancer therapies discovered by the University of Texas’ M.D. Anderson Cancer Center to create a first-of-its kind nonviral gene therapy treatment that targets cancer by supercharging a patient’s immune system. The collaborative approach of pooling separate intellectual property underlying two distinct sets of technologies created by two institutions is uncommon for research universities, representing a strong commitment in working together to tackle the grand challenge of cancer.

The institutions’ combined technology recently spurred a landmark $100 million exclusive licensing deal with biotech company Intrexon Corp. and pharmaceutical company Ziopharm Oncology. The deal, a key part in getting the treatment to market, paid the U of M and M.D. Anderson up front for use of the technology instead of designating royalties to be paid after product launch years in the future. A portion of the funds will be shared with the U of M, which will provide substantial support for future research.

For more about the U of M’s contribution, a DNA-based gene delivery platform called “Sleeping Beauty” developed by Perry Hackett, professor of genetics, cell development and biology and a member of the Masonic Cancer Center’s Genetic Mechanisms of Cancer Program, and his co-inventors, see the full story in CBS Connect.

Kevin Coss

Kevin Coss

Kevin is a communications specialist with the Office of the Vice President for Research.

coss@umn.edu

Latest Blog Posts

Spiral staircase with golden ratio design

The University of Minnesota continues to steadily grow its research activities, maintaining its rank among the nation’s top 10 public research institutions.

Read More
Categories:
Turkeys on a farm

College of Veterinary Medicine experts are helping Minnesota's turkey industry, an important source of livelihood for independent farms, navigate current challenges.

Read More
Senior man sleeping

Using deep brain stimulation, researchers aim to treat a less visible and sometimes overlooked symptom of Parkinson's disease: sleep disturbances.

Read More
U of M researchers and staff, along with an MHTA staff member, gather for a photo at the Tekne Awards event

At an event hosted by the Minnesota High Tech Association, U startups Anatomi, Calyxt, and NovoClade were each recognized for their achievements.

Read More